Literature DB >> 5902706

Progress in tetanus prophylaxis: the advent of human antitoxin.

B J Perey.   

Abstract

Injections of tetanus antitoxin of animal origin frequently cause serious disability and sometimes death. Despite world-wide knowledge of these effects, millions of prophylactic injections of equine tetanus antitoxin are given annually, and it is continually proposed that the dosage be increased in order to obtain higher "protective" levels in the serum, a procedure which would increase the incidence and severity of reactions. Furthermore, equine antitoxin frequently fails to prevent tetanus.Tetanus antitoxin of human origin is available which carries no risk of complications and confers a higher degree of immunity more quickly than equine antitoxin. The cost of treating reactions to horse serum, together with the financial loss incurred by work-absence, far outweighs the cost of human antitoxin. In the author's opinion, the use, in this country, of antitoxin of animal origin is no longer medically acceptable and may well prove legally indefensible.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5902706      PMCID: PMC1935316     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  37 in total

1.  The persistence in the human circulation of horse and human tetanus antitoxins.

Authors:  J SMOLENS; A B VOGT; M N CRAWFORD; J STOKES
Journal:  J Pediatr       Date:  1961-12       Impact factor: 4.406

2.  Reappraisal of tetanus prophylaxis.

Authors:  S B HARPER
Journal:  Wis Med J       Date:  1962-12

3.  Antibody response to tetanus toxoid 15 years after initial immunization.

Authors:  J R MCCARROLL; I ABRAHAMS; P A SKUDDER
Journal:  Am J Public Health Nations Health       Date:  1962-10

4.  Rapid destruction of antitetanus serum in a patient previously sensitised to horse serum.

Authors:  M P GODFREY; V PARSONS; J R RAWSTRON
Journal:  Lancet       Date:  1960-12-03       Impact factor: 79.321

5.  Immunologic studies of serum sickness from bovine antitetanus toxin.

Authors:  R E REISMAN; N R ROSE; C E ARBESMAN
Journal:  JAMA       Date:  1961-06-24       Impact factor: 56.272

6.  The use of A.T.S. in the treatment and prophylaxis of tetanus.

Authors:  G P WRIGHT
Journal:  Proc R Soc Med       Date:  1958-12

7.  Fatal tetanus in a boy after prophylactic tetanus antitoxin.

Authors:  A H LITTLEWOOD; A K MANT; G P WRIGHT
Journal:  Br Med J       Date:  1954-08-21

8.  Serum-sickness and local reactions in tetanus prophylaxis; a study of 400 cases.

Authors:  N H MOYNIHAN
Journal:  Lancet       Date:  1955-08-06       Impact factor: 79.321

9.  The effect of chlorotetracycline and oxytetracycline on Cl. tetani in vitro and in vivo.

Authors:  O LENNERT-PETERSEN
Journal:  Acta Pathol Microbiol Scand       Date:  1954

10.  Tetanus in California; epidemiology and a review of 232 cases.

Authors:  P K CONDIT
Journal:  Calif Med       Date:  1959-05
View more
  3 in total

Review 1.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1967-03       Impact factor: 2.401

2.  Recruitment and plasmapheresis of donors to provide human antitetanus immunoglobulin.

Authors:  I A Cook; D W Ross; I Gordon
Journal:  J Clin Pathol       Date:  1976-03       Impact factor: 3.411

Review 3.  Eradication of tetanus.

Authors:  C L Thwaites; H T Loan
Journal:  Br Med Bull       Date:  2015-11-22       Impact factor: 4.291

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.